Calidi Biotherapeutics Names Guy Travis Clifton Chief Medical Officer - Quick Facts

(RTTNews) - Calidi Biotherapeutics (CLDI) announced the appointment of Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor. Clifton is a practicing surgical oncologist with over 17 years of experience in drug development, early phase and translational clinical trials, and cancer immunotherapy. From 2013 to current, he has served as a practicing surgical oncologist in the US Army. He also served as the Chief Medical Officer and co-founder of Parthenon Therapeutics/Incendia Therapeutics from October 2020 to August 2024.

"With our recently filed IND for a company sponsored, dose escalation trial of CLD-201 in adult patients with solid tumors, Cliftons oncology and advisory experience will be invaluable to us and our goal to advance our stem cell-based and enveloped virus platforms through the clinic and to patients in need," said Allan Camaisa, CEO, Calidi Biotherapeutics.

For More Such Health News, visit rttnews.com.